A stepwise increased dose of auranofin does not influence gastrointestinal side-effects

Clin Exp Rheumatol. 1997 Jul-Aug;15(4):454-5.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antirheumatic Agents / administration & dosage*
  • Antirheumatic Agents / adverse effects
  • Arthritis, Rheumatoid / drug therapy*
  • Auranofin / administration & dosage*
  • Auranofin / adverse effects
  • Diarrhea / chemically induced
  • Double-Blind Method
  • Gastrointestinal Diseases / chemically induced
  • Gastrointestinal Diseases / prevention & control*
  • Humans
  • Severity of Illness Index

Substances

  • Antirheumatic Agents
  • Auranofin